Skip to content
Bayh-Dole at 45: Still an engine for innovation
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the […]
Bayh-Dole at 45: Still an engine for innovation Read More »
House passes BIO-backed legislation to increase access to capital
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the House Dec. 11—a move
House passes BIO-backed legislation to increase access to capital Read More »
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to
BIO-CSBA report explains why and how states seek to attract biotech Read More »
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11
BIO on the American Road: Indiana, a production powerhouse, is still expanding Read More »
Ahead of BIO IP Conference, research highlights why biotech needs strong patents
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship
Ahead of BIO IP Conference, research highlights why biotech needs strong patents Read More »
PACE panel urges incentives for exciting new GTT drugs
Luke Rosen had hoped a new treatment would slow the progression of his daughter’s KIF1A Associated Neurological Disorder (KAND), but was amazed to see
PACE panel urges incentives for exciting new GTT drugs Read More »
BIO CEO John Crowley tells Senate how to support biotech
Maintaining America’s biotechnology leadership requires Food and Drug Administration (FDA) modernization as well as Congressional action to reauthorize a program supporting rare disease research
BIO CEO John Crowley tells Senate how to support biotech Read More »
PACE: CDER director discusses faster approval, FDA morale with BIO CEO John F. Crowley
The FDA is hiring reviewers and finding ways to expedite drug approval, Dr. George Tidmarsh, Director of the Food and Drug Administration (FDA) Center
PACE: CDER director discusses faster approval, FDA morale with BIO CEO John F. Crowley Read More »
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures will drive many of
BIO PACE 2025: Patients need to ensure state policies enable access to medicine Read More »
Senators seek patent clarity to support innovation
Legislation establishing clear rules about the kinds of ideas that can be patented would support innovation in biotech and other fields by eliminating ambiguities
Senators seek patent clarity to support innovation Read More »